Johnson & Johnson Other Current Liabilities

As of the most recent data (June 2026), JNJ shows a other current liabilities of $33B. That compares with $32B in the prior-year period — up 4.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JNJ's other current liabilities is now $33B (was $32B) — a 4.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Johnson & Johnson is outperforming or lagging.

Tracking JNJ's other current liabilities over time shows whether Johnson & Johnson is scaling, shrinking, or reshaping that part of the business. The current reading is $33B That compares with $32B in the prior-year period — up 4.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Johnson & Johnson's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $33B) with ownership activity and broader fundamentals.

Johnson & Johnson's other current liabilities is $33B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.